IP Library Granted Patent US 10,501,525
Granted Patent B2
US 10,501,525 · App. 14/423,802 · Granted Dec 10, 2019

Methods for purification of antibodies using aliphatic alcohols

Inventors: Alois Jungbauer (Vienna, AT); Peter Satzer (Vienna, AT); Anne-Luise Tscheliessnig (Ledenitzen, AT)
Assignee: Novartis AG
C07K16/00C07K1/30C07K16/065
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,501,525
App. No.
14/423,802
Granted
Dec 10, 2019
Kind
B2
Abstract

This disclosure relates to methods for isolating antibodies from cell-free culture supernatant.

Claims (34)

1. A method for isolating a protein from a cell culture supernatant, the method comprising:

a) combining a cell culture supernatant with a divalent cation salt under conditions suitable for the precipitation of impurities in the supernatant to produce a primary supernatant;

b) combining the primary supernatant with an aliphatic alcohol under conditions suitable for forming a protein-containing precipitate and isolating the protein-containing precipitate;

c) re-suspending the protein-containing precipitate in a buffer comprising a divalent cation salt under conditions suitable for the precipitation of impurities therefrom to produce a protein-containing solution; and,

d) combining the protein-containing solution with an aliphatic alcohol under conditions suitable for forming a purified protein-containing precipitate and isolating the purified protein-containing precipitate.

2. The method of claim 1 wherein the aliphatic alcohol is ethanol.

3. The method of claim 1 wherein the conditions of step a) comprise a phosphate concentration of less than or equal to about 6 mM.

4. The method of claim 1 wherein the conditions of step c) comprise a phosphate concentration of less than about 6 mM.

5. The method of claim 1 wherein the conditions in each of the steps comprise a pH of about 6.5 to about 8.5.

6. The method of claim 1 wherein the divalent cation salt is CaCl 2 .

7. The method of claim 1 wherein the conditions of steps a) and c) comprise a conductivity of about 8-80 mS/cm.

8. The method of claim 1 carried out at a temperature of from about −10° C. to about 4° C.

9. The method of claim 1 wherein the conditions of steps b) and d) are selected from the group consisting of a pH of about 6.5, a final concentration (v/v) of aliphatic alcohol of about 25%, and a temperature of about −10° C.

10. The method of claim 1 wherein the protein is an antibody.

11. The method of claim 10 , the method comprising:

a) combining a cell-free culture supernatant with CaCl 2 at about pH 8.5 and removing any resulting precipitate to produce a primary supernatant;

b) combining the primary supernatant with ethanol from a stock solution of less than about 50% over a time period of about 60 minutes or a feeding rate of about 30 μl/min or less at about pH 6.5 and isolating the antibody-containing precipitate;

c) re-suspending the antibody-containing precipitate in a buffer comprising CaCl 2 at about pH 8.5 and removing any resulting precipitate to produce an antibody-containing solution; and,

d) combining the antibody-containing solution with ethanol from a stock solution of less than about 50% over a time period of about 60 minutes or a feeding rate of about 30 μl/min or less at about pH 6.5 and isolating the purified antibody-containing precipitate.

12. The method of claim 1 wherein the cell culture supernatant is a cell-free culture supernatant.

13. A method for isolating a protein from a cell culture supernatant, the method comprising:

a) combining a cell culture supernatant comprising the protein with an aliphatic alcohol under conditions suitable for forming a protein-containing precipitate and isolating the protein-containing precipitate;

b) re-suspending the protein-containing precipitate in a buffer comprising a divalent cation salt under conditions suitable for the precipitation of impurities therefrom to produce a protein-containing solution; and,

c) combining the protein-containing solution with an aliphatic alcohol under conditions suitable for forming a purified protein-containing precipitate and isolating the purified protein-containing precipitate.

14. The method of claim 13 wherein the protein is an antibody.

15. The method of claim 14 , the method comprising:

a) combining a primary supernatant derived from a cell-free culture supernatant with ethanol from a stock solution of less than about 50% over a time period of about 60 minutes or a feeding rate of about 30 μl/min or less at about pH 6.5 and isolating the antibody-containing precipitate;

b) re-suspending the antibody-containing precipitate in a buffer comprising CaCl 2 at about pH 8.5 and removing any resulting precipitate to produce an antibody-containing solution; and,

c) combining the antibody-containing solution with ethanol from a stock solution of less than about 50% over a time period of about 60 minutes or a feeding rate of about 30 μl/min or less at about pH 6.5 and isolating the purified antibody-containing precipitate.

16. The method of claim 13 wherein the cell culture supernatant is a cell-free culture supernatant.

17. The method of claim 13 wherein the aliphatic alcohol is ethanol.

18. The method of claim 13 wherein the divalent cation salt is CaCl 2 .

19. The method of claim 13 wherein the conditions of step b) comprise a phosphate concentration of less than 6 mM.

20. The method of claim 13 wherein the conditions in each of the steps comprise a pH of about 6.5 to about 8.5.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 11, 2026
From: NOVARTIS AG
To: NOVARTIS PHARMA AG
Reel/Frame 075712/0291 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 1, 2015
From: JUNGBAUER, ALOIS; SATZER, PETER; TSCHELIESSNIG, ANNE-LUISE
To: UNIVERSITY OF NATURAL RESOURCES AND LIFE SCIENCES, VIENNA
Reel/Frame 035312/0818 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 1, 2015
From: UNIVERSITY OF NATURAL RESOURCES AND LIFE SCIENCES, VIENNA
To: NOVARTIS PHARMA AG
Reel/Frame 035312/0920 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 1, 2015
From: NOVARTIS PHARMA AG
To: NOVARTIS AG
Reel/Frame 035312/0972 →
Continuity (2)
Provisional Application 61693957 · Aug 28, 2012
Related Publication 20150225473A1 · Aug 13, 2015